Showing results (21-30 of 111) with videos related to
Sort By:
Pageof 12
Current Treatment Options in Gastroenterology|October 12, 2016
Newest Drugs for Chronic Unexplained Nausea and VomitingWilliam L HaslerDrug Safety|July 3, 2004
Safety profile of tegaserod, a 5-HT4 receptor agonist, for the treatment of irritable bowel syndromeWilliam L Hasler, Philip SchoenfeldAmerican Journal of Physiology. Gastrointestinal and Liver Physiology|June 18, 2002
Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. VI. Pathogenesis and therapeutic approaches to human gastric dysrhythmiasChung Owyang, William L HaslerGastroenterology & Hepatology|February 21, 2012
A technical review and clinical assessment of the wireless motility capsuleRichard J Saad, William L HaslerGastroenterology & Hepatology|May 26, 2021
Functional Dyspepsia: A Review of the Symptoms, Evaluation, and Treatment OptionsKimberly N Harer, William L HaslerCurrent Treatment Options in Gastroenterology|September 8, 2017
Diabetes and the StomachAllen A Lee, William L HaslerNature Reviews. Gastroenterology & Hepatology|May 9, 2012
New vision in video capsule endoscopy: current status and future directionsLaurel R Fisher, William L HaslerExpert Review of Gastroenterology & Hepatology|October 25, 2025
Impact of GLP-1 receptor agonists on gastrointestinal function and symptomsRosita D Frazier, William L HaslerCurrent Treatment Options in Gastroenterology|November 4, 2016
Opioids and GI Motility-Friend or Foe?Allen A Lee, William L HaslerThe American Journal of Gastroenterology|July 5, 2006
Modulation of intestinal gas dynamics in healthy human volunteers by the 5-HT receptor agonist tegaserodRadoslav Coleski, Chung Owyang, William L HaslerPageof 12